Literature DB >> 11909006

Management of children with severe asthma exacerbation in the emergency department.

Benjamin Volovitz1, Moshe Nussinovitch.   

Abstract

Although acute asthma is a very common cause of emergency department visits in children, there is as yet insufficient evidence for the establishment of a standardized treatment protocol. The aim of this review is to describe updated information on the management of asthma exacerbations in the pediatric emergency department. Oxygen is the first-line treatment of acute asthma exacerbations in the emergency department to control hypoxemia. It is accompanied by the administration of beta(2)-adrenoceptor agonists followed by corticosteroids. beta(2)-Adrenoceptor agonists have traditionally been administered by nebulization, although spacers have recently been introduced and proven, in many cases, to be as effective as nebulization. Oral prednisolone, with its reliability, simplicity, convenience and low cost, should remain the treatment of choice for the most severe asthma exacerbations, when the lung airways are extremely contracted and filled with secretions. Recently, several studies have shown that high-dose inhaled corticosteroids are at least as effective as oral corticosteroids in controlling moderate to severe asthma attacks in children and therefore should be considered an alternative treatment to oral corticosteroids in moderate to severe asthma attacks. Studies of other drugs have shown that ipratropium bromide may be given only in addition to beta(2)-adrenoceptor agonists; theophylline has no additional benefit, and magnesium sulfate has no clear advantage. Comprehensive asthma management should also include asthma education, measures to prevent asthma triggers, and training in the use of inhalers and spacers. Proper management will avoid most asthma attacks and reduce admission and readmission to emergency departments.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11909006     DOI: 10.2165/00128072-200204030-00001

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN: 1174-5878            Impact factor:   3.022


  71 in total

1.  Air or oxygen as driving gas for nebulised salbutamol.

Authors:  J G Gleeson; S Green; J F Price
Journal:  Arch Dis Child       Date:  1988-08       Impact factor: 3.791

2.  Poor inhalation technique, even after inhalation instructions, in children with asthma.

Authors:  A W Kamps; B van Ewijk; R J Roorda; P L Brand
Journal:  Pediatr Pulmonol       Date:  2000-01

3.  Inhaled budesonide in acute asthma.

Authors:  S Singhi; S Banerjee; H Nanjundaswamy
Journal:  J Paediatr Child Health       Date:  1999-10       Impact factor: 1.954

Review 4.  Corticosteroids for preventing relapse following acute exacerbations of asthma.

Authors:  B H Rowe; C H Spooner; F M Ducharme; J A Bretzlaff; G W Bota
Journal:  Cochrane Database Syst Rev       Date:  2000

5.  Methylprednisolone therapy for acute asthma in infants and toddlers: a controlled clinical trial.

Authors:  A Tal; N Levy; J E Bearman
Journal:  Pediatrics       Date:  1990-09       Impact factor: 7.124

6.  Structured discharge procedure for children admitted to hospital with acute asthma: a randomised controlled trial of nursing practice.

Authors:  L J Wesseldine; P McCarthy; M Silverman
Journal:  Arch Dis Child       Date:  1999-02       Impact factor: 3.791

Review 7.  The role of anticholinergic antimuscarinic bronchodilator therapy in children.

Authors:  M Silverman
Journal:  Lung       Date:  1990       Impact factor: 2.584

8.  Effectiveness and safety of inhaled corticosteroids in controlling acute asthma attacks in children who were treated in the emergency department: a controlled comparative study with oral prednisolone.

Authors:  B Volovitz; L Bentur; Y Finkelstein; Y Mansour; S Shalitin; M Nussinovitch; I Varsano
Journal:  J Allergy Clin Immunol       Date:  1998-10       Impact factor: 10.793

9.  Efficacy of albuterol administered by nebulizer versus spacer device in children with acute asthma.

Authors:  E Kerem; H Levison; S Schuh; H O'Brodovich; J Reisman; L Bentur; G J Canny
Journal:  J Pediatr       Date:  1993-08       Impact factor: 4.406

10.  Randomized controlled trial of ipratropium bromide and frequent low doses of salbutamol in the management of mild and moderate acute pediatric asthma.

Authors:  F M Ducharme; G M Davis
Journal:  J Pediatr       Date:  1998-10       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.